169 related articles for article (PubMed ID: 16385346)
1. Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns.
Avniel S; Arik Z; Maly A; Sagie A; Basst HB; Yahana MD; Weiss ID; Pal B; Wald O; Ad-El D; Fujii N; Arenzana-Seisdedos F; Jung S; Galun E; Gur E; Peled A
J Invest Dermatol; 2006 Feb; 126(2):468-76. PubMed ID: 16385346
[TBL] [Abstract][Full Text] [Related]
2. CXCL12 and CXCR4 expression by human gingival fibroblasts in periodontal disease.
Hosokawa Y; Hosokawa I; Ozaki K; Nakae H; Murakami K; Miyake Y; Matsuo T
Clin Exp Immunol; 2005 Sep; 141(3):467-74. PubMed ID: 16045736
[TBL] [Abstract][Full Text] [Related]
3. Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS).
Ding J; Hori K; Zhang R; Marcoux Y; Honardoust D; Shankowsky HA; Tredget EE
Wound Repair Regen; 2011; 19(5):568-78. PubMed ID: 22092795
[TBL] [Abstract][Full Text] [Related]
4. CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair.
Hu C; Yong X; Li C; Lü M; Liu D; Chen L; Hu J; Teng M; Zhang D; Fan Y; Liang G
J Surg Res; 2013 Jul; 183(1):427-34. PubMed ID: 23462453
[TBL] [Abstract][Full Text] [Related]
5. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.
Bradfield PF; Amft N; Vernon-Wilson E; Exley AE; Parsonage G; Rainger GE; Nash GB; Thomas AM; Simmons DL; Salmon M; Buckley CD
Arthritis Rheum; 2003 Sep; 48(9):2472-82. PubMed ID: 13130466
[TBL] [Abstract][Full Text] [Related]
6. CTACK/CCL27 accelerates skin regeneration via accumulation of bone marrow-derived keratinocytes.
Inokuma D; Abe R; Fujita Y; Sasaki M; Shibaki A; Nakamura H; McMillan JR; Shimizu T; Shimizu H
Stem Cells; 2006 Dec; 24(12):2810-6. PubMed ID: 16931770
[TBL] [Abstract][Full Text] [Related]
7. Characterization and functionality of CXCR4 chemokine receptor and SDF-1 in human corneal fibroblasts.
Bourcier T; Berbar T; Paquet S; Rondeau N; Thomas F; Borderie V; Laroche L; Rostène W; Haour F; Lombet A
Mol Vis; 2003 Apr; 9():96-102. PubMed ID: 12677165
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 enhances adhesion of B16 tumor cells to endothelial cells in vitro and in vivo via beta(1) integrin.
Cardones AR; Murakami T; Hwang ST
Cancer Res; 2003 Oct; 63(20):6751-7. PubMed ID: 14583470
[TBL] [Abstract][Full Text] [Related]
9. Stromal cell-derived factor 1 (CXCL12) binds to endothelial cells and signals through a receptor different from CXCR4.
Hatse S; Balzarini J; Liekens S
Biochem Biophys Res Commun; 2006 Sep; 348(1):192-9. PubMed ID: 16875673
[TBL] [Abstract][Full Text] [Related]
10. The role of CXCL12 in the organ-specific process of artery formation.
Ara T; Tokoyoda K; Okamoto R; Koni PA; Nagasawa T
Blood; 2005 Apr; 105(8):3155-61. PubMed ID: 15626744
[TBL] [Abstract][Full Text] [Related]
11. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
[TBL] [Abstract][Full Text] [Related]
12. T-helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal-derived factor-1alpha (CXCL12).
Dulkys Y; Buschermöhle T; Escher SE; Kapp A; Elsner J
Clin Exp Allergy; 2004 Oct; 34(10):1610-20. PubMed ID: 15479278
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cDNA and genomic sequences encoding a canine chemokine receptor, CXCR4 and its ligand CXCL12.
Tsuchida S; Kagi A; Takahashi T
Vet Immunol Immunopathol; 2007 Apr; 116(3-4):219-25. PubMed ID: 17316828
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
[TBL] [Abstract][Full Text] [Related]
15. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T
FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism.
Carr AN; Howard BW; Yang HT; Eby-Wilkens E; Loos P; Varbanov A; Qu A; DeMuth JP; Davis MG; Proia A; Terjung RL; Peters KG
Cardiovasc Res; 2006 Mar; 69(4):925-35. PubMed ID: 16409996
[TBL] [Abstract][Full Text] [Related]
17. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
Wang J; Loberg R; Taichman RS
Cancer Metastasis Rev; 2006 Dec; 25(4):573-87. PubMed ID: 17165132
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications.
Cipriani P; Franca Milia A; Liakouli V; Pacini A; Manetti M; Marrelli A; Toscano A; Pingiotti E; Fulminis A; Guiducci S; Perricone R; Kahaleh B; Matucci-Cerinic M; Ibba-Manneschi L; Giacomelli R
Arthritis Rheum; 2006 Sep; 54(9):3022-33. PubMed ID: 16948134
[TBL] [Abstract][Full Text] [Related]
19. Structural localization and expression of CXCL12 and CXCR4 in rat heart and isolated cardiac myocytes.
Segret A; Rücker-Martin C; Pavoine C; Flavigny J; Deroubaix E; Châtel MA; Lombet A; Renaud JF
J Histochem Cytochem; 2007 Feb; 55(2):141-50. PubMed ID: 17046839
[TBL] [Abstract][Full Text] [Related]
20. The stromal derived factor-1/CXCL12-CXC chemokine receptor 4 biological axis in non-small cell lung cancer metastases.
Phillips RJ; Burdick MD; Lutz M; Belperio JA; Keane MP; Strieter RM
Am J Respir Crit Care Med; 2003 Jun; 167(12):1676-86. PubMed ID: 12626353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
